Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Medecine Sciences : M/S|May 8, 2014
[ROS and NADPH oxidase: key regulators of tumor vascularisation]Sarah Garrido-Urbani, Vincent Jaquet, Beat A Imhof
Medecine Sciences : M/S|March 30, 2010
[Nectin and nectin-like molecules as markers, actors and targets in cancer]Gaëlle Fournier, Sarah Garrido-Urbani, Nicolas Reymond, et al.
FEBS Letters|April 7, 2005
PICK-1: a scaffold protein that interacts with Nectins and JAMs at cell junctionsNicolas Reymond, Sarah Garrido-Urbani, Jean-Paul Borg, et al.
Biochemical Society Transactions|March 28, 2008
Vascular and epithelial junctions: a barrier for leucocyte migrationSarah Garrido-Urbani, Paul F Bradfield, Boris P-L Lee, et al.
The Journal of Biological Chemistry|March 24, 2005
Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17Stéphanie Fabre-Lafay, Sarah Garrido-Urbani, Nicolas Reymond, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 12, 2009
Sushi repeat protein X-linked 2, a novel mediator of angiogenesisMarijana Miljkovic-Licina, Philippe Hammel, Sarah Garrido-Urbani, et al.
Life Science Alliance|June 29, 2019
Inhibition of host NOX1 blocks tumor growth and enhances checkpoint inhibitor-based immunotherapyJimmy Stalin, Sarah Garrido-Urbani, Freddy Heitz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 30, 2020
Olfactomedin-like 3 promotes PDGF-dependent pericyte proliferation and migration during embryonic blood vessel formationBeat A Imhof, Romain Ballet, Philippe Hammel, et al.
The Journal of Biological Chemistry|March 27, 2004
A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutionsJérôme Deval, Jean-Marc Navarro, Boulbaba Selmi, et al.
Molecular Cancer Therapeutics|September 25, 2012
Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverageMarijana Miljkovic-Licina, Philippe Hammel, Sarah Garrido-Urbani, et al.
Pageof 2